Related Experiment Video
Updated: Apr 21, 2026

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
Published on: March 14, 2017
Red blood cell transfusion is a determinant of neurological complications after cardiac surgery
Giovanni Mariscalco1, Fausto Biancari2, Tatu Juvonen2
1Department of Heart and Vessels, Cardiac Surgery Unit, Varese University Hospital, Varese, Italy giovannimariscalco@yahoo.it.
Insights
Red blood cell (RBC) transfusions after cardiac surgery increase the risk of stroke and transient ischemic attack (TIA). Even transfusing more than two RBC units significantly elevates these risks, highlighting the need for careful transfusion management.
Area of Science:
- Cardiovascular Surgery
- Neurology
- Transfusion Medicine
Background:
- Cardiac surgery patients often require red blood cell (RBC) transfusions.
- The association between RBC transfusions and postoperative neurological events like stroke and transient ischemic attack (TIA) requires further investigation.
Purpose of the Study:
- To evaluate the impact of RBC transfusions on the incidence of stroke and TIA following cardiac surgery.
- To determine if the amount of RBCs transfused correlates with the risk of these neurological events.
Main Methods:
- A retrospective analysis of 14,956 patients undergoing coronary artery bypass grafting (CABG) and/or valve surgery at three European University Hospitals.
- Logistic regression and multilevel propensity score analysis were employed to assess the prognostic impact of RBC transfusion on postoperative stroke and TIA.
Main Results:
- RBC transfusion was identified as an independent predictor of postoperative stroke and TIA.
- An increased number of transfused RBC units correlated with higher rates of stroke and TIA.
- Transfusion of 6 or more RBC units was associated with a significantly elevated risk of stroke (3.9%) and TIA (5.9%).
Conclusions:
- Transfusion of more than 2 units of RBCs after cardiac surgery is linked to a significantly increased risk of postoperative stroke and TIA.
- These findings underscore the importance of judicious RBC transfusion strategies in cardiac surgery patients to mitigate neurological complications.
Objectives:
The aim of this study was to evaluate the impact of red blood cell (RBC) transfusions on the occurrence of stroke and transient ischaemic attack (TIA) after cardiac surgery.
Methods:
Data on 14 956 patients undergoing coronary artery bypass grafting (CABG) and valve surgery (with or without concomitant CABG) were retrieved at three European University Hospitals. The prognostic impact of RBC transfusion on postoperative stroke and TIA was investigated by logistic regression and multilevel propensity score analysis.
Results:
Postoperative stroke was observed in 147 (1.0%) patients and combined stroke/TIA in 238 (1.6%). Of the total population, 6439 (43%) patients received RBC transfusion with a median of 2 units (25th-75th percentile, 2-4 units). When adjusted for other significant risk factors, RBC transfusion was an independent predictor of stroke [odds ratio (OR) 1.14; 95% confidence interval (CI) 1.11-1.17 per unit] and stroke/TIA (OR 1.12; 95% CI 1.09-1.15 per unit). Increase in the amount of transfused RBC units was associated with higher rates of stroke (no RBC transfusion: 0.5%, 1-2 RBC units: 1.0%, OR 1.42; >2 RBC units: 2.7%, OR 3.10) and stroke/TIA (no RBC transfusion: 0.8%, 1-2 RBC units: 1.8%, OR 1.49; >2 RBC units: 4.0%, OR 2.72). Multilevel propensity score analysis confirmed these findings and showed a very high risk of stroke (3.9%; OR 3.85; 95% CI 2.30-6.45) and stroke/TIA (5.9%; OR 3.30; 95% CI 2.17-5.02) associated with transfusion of ≥6 units of RBCs.
Conclusions:
Transfusion of more than 2 units of RBCs after cardiac surgery is associated with a significantly increased risk of postoperative stroke and TIA.
Related Concept Videos
Blood Transfusion
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
Blood Transfusion and Agglutination
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Hemorrhagic Stroke ll: Pathophysiology
Rh Blood Group

